Retirement Planning Group (New York)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
4,079
+1
+0% +$215 0.56% 36
2026
Q1
$887K Buy
4,078
+1
+0% +$222 0.57% 34
2025
Q4
$932K Sell
4,077
-5
-0.1% -$1.14K 0.64% 33
2025
Q3
$945K Buy
4,082
+6
+0.1% +$1.22K 0.71% 32
2025
Q2
$757K Hold
4,076
0.66% 31
2025
Q1
$854K Buy
4,076
+30
+0.7% +$5.83K 0.87% 29
2024
Q4
$719K Buy
+4,046
New +$744K 0.79% 27

Other funds holding ABBV

Retirement Planning Group (New York)'s ABBV Position: Q2 2026 in Review

Retirement Planning Group (New York) increased its AbbVie (ABBV) stake by 0.02% in Q2 2026, buying an estimated $215 and bringing the position to 4,079 shares worth $1.03M. The position accounts for 0.56% of the portfolio, ranked #36.

Retirement Planning Group (New York) first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,220 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Retirement Planning Group (New York) held 4,079 shares of AbbVie worth $1.03M as of Q2 2026.
  • Retirement Planning Group (New York) bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.56% of Retirement Planning Group (New York)'s portfolio in Q2 2026, its #36 holding.
  • Retirement Planning Group (New York) first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,220 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Retirement Planning Group (New York)'s 13F filing for Q2 2026, filed 7 Aug 2026.